HIV-related admissions to a district general hospital in the UK: A single centre study

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 9, Issue 4, 2009, Pages 333-337

  Udayaraj, Udaya P ^a   Tang, Alan ^a   Vaux, Emma ^a   Barker, Lindsey ^a   Naik, Ramesh B ^a  

^a ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

Author keywords

Costs; District general hospital; Ethnicity; HIV; Immigrants; Mortality

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DRUG COST; ETHNICITY; FEMALE; HEALTH CARE COST; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMIGRANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PUBLIC HOSPITAL; SCREENING TEST; SEROCONVERSION; TREATMENT DURATION; UNITED KINGDOM; VIRUS LOAD;

EID: 70249084576     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.9-4-333     Document Type: Article

References (15)

1. The UK collaborative group for HIV and STI surveillance. Mapping the issues. HIV and other sexually transmitted infections in the United Kingdom. London: Health Protection Agency, 2005
2. Mocroft A, Katlama C, Johnson AM et al. AIDS across Europe, 1994-98: The EuroSIDA study. Lancet 2000;356:291-6.
3. Mouton Y, Alfandari S, Valette M et al. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Federation National des Centres de Lutte contre le SIDA. AIDS 1997;11:F101-5.
4. Palella FJ, Jr, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
5. Beck E, Mandalia S, Youle M et al. Treatment outcome and cost effectiveness of different HAART regimens in the UK 1996-2002. Int J STD AIDS 2008;19:297-304.
6. Beck E, Mandalia S, Koukounar A, Youle M, Gazzard B. Use and cost of HIV service provision in UK NPMS-HHC sites: Aggregate analyses January 1996-2002. London: NPMS-HHC Coordinating and Analytic Centre, Chelsea and Westminster Hospital Trust, 2004.
7. Centre for Infections, Health Protection Agency. Survey of prevalent HIV infections diagnosed (SOPHID). London: HPA, 2003.
8. Office for National Statistics. UK census. London: ONS, 2001.
9. Sullivan AK, Curtis H, Sabin CA, Johnson MA. Newly diagnosed HIV infections: Review in UK and Ireland. BMJ 2005;330:1301-2.
10. Sherer R, Pulvirenti J, Stieglitz K et al. Hospitalization in HIV in Chicago. J Int Assoc Physicians AIDS Care (Chic Ill) 2002;1:26-33.
11. Hogg RS, Raboud J, Bigham M et al. Relation between hospital HIV/ AIDS caseload and mortality among persons with HIV/AIDS in Canada. Clin Invest Med 1998;21:27-32.
12. Evans B, Sadler K. HIV in the UK - what is going on? AIDS Hepatitis Digest 2003;93:1-4.
13. Krentz HB, Auld MC, Gill MJ. The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med 2004;5:93-8.
14. Keiser P, Nassar N, Kvanli MB et al. Long-term impact of highly active antiretroviral therapy on HIV-related health care costs. J Acquir Immune Defic Syndr 2001;27:14-9.
15. Department of Health. Guidance on eligibility for free hospital treatment under the NHS. London: DH, 2004.